$TGEN
TECOGEN INC. Stock $tgen

$tgen Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000153743523000021 Filed on March 23, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$5.380M	$4.532M	$25.00M
YoY Change	-27.67%	-36.89%	2.48%
Cost Of Revenue	$3.288M	$2.152M	$13.94M
YoY Change	-24.37%	-42.27%	8.78%
Gross Profit	$2.092M	$2.379M	$11.07M
YoY Change	-32.32%	-31.07%	-4.49%
Gross Profit Margin	38.88%	52.5%	44.26%
Selling, General & Admin	$3.542M	$3.506M	$12.72M
YoY Change	17.67%	10.89%	3.69%
% of Gross Profit	169.3%	147.36%	114.94%
Research & Development	$229.1K	$195.8K	$732.9K
YoY Change	63.49%	21.57%	35.2%
% of Gross Profit	10.95%	8.23%	6.62%
Depreciation & Amortization	$105.9K	$103.4K	$428.3K
YoY Change	-1.07%	-7.87%	-8.83%
% of Gross Profit	5.06%	4.35%	3.87%
Operating Expenses	$3.771M	$3.702M	$13.42M
YoY Change	19.71%	11.4%	4.76%
Operating Profit	-$1.450M	-$1.322M	-$2.349M
YoY Change	-1890.27%	-1123.95%	92.7%
Interest Expense	$415.00	-$31.33K	$16.26K
YoY Change	-49.88%	-57.39%	14.17%
% of Operating Profit
Other Income/Expense, Net	$415.00		-$32.22K
YoY Change	-102.93%		-100.65%
Pretax Income	-$1.449M	-$1.430M	-$2.381M
YoY Change	-1500.35%	-2262.45%	-163.33%
Income Tax	$22.64K	$0.00	$16.35K
% Of Pretax Income
Net Earnings	-$1.490M	-$1.424M	-$2.448M
YoY Change	-1766.53%	-2362.05%	-166.23%
Net Earnings / Revenue	-27.7%	-31.43%	-9.79%
Basic Earnings Per Share	-$0.06		-$0.10
Diluted Earnings Per Share	-$0.06	-$0.06	-$0.10
COMMON SHARES
Basic Shares Outstanding	24.85M shares		24.85M shares
Diluted Shares Outstanding	24.85M shares		24.85M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.629M	$1.914M	$1.914M
YoY Change	-70.17%	-47.05%	-47.05%
Cash & Equivalents	$1.629M	$1.914M	$1.914M
Short-Term Investments
Other Short-Term Assets	$265.0K	$401.2K	$401.2K
YoY Change	-54.05%	-30.69%	-30.69%
Inventory	$11.86M	$10.48M	$10.48M
Prepaid Expenses
Receivables	$6.758M	$6.714M	$1.805M
Other Receivables	$46.15K	$7.427M	$7.427M
Total Short-Term Assets	$22.35M	$22.03M	$22.03M
YoY Change	-12.72%	-11.79%	-11.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.290M	$1.408M	$2.653M
YoY Change	-24.37%	-21.05%	-27.35%
Goodwill	$2.406M	$2.406M
YoY Change	0.0%	0.0%
Intangibles	$947.9K	$997.6K
YoY Change	-16.92%	-15.53%
Long-Term Investments	$93.74K	$93.74K	$93.74K
YoY Change
Other Assets	$164.8K	$165.2K	$165.2K
YoY Change	-11.02%	11.54%	11.54%
Total Long-Term Assets	$5.893M	$6.222M	$6.222M
YoY Change	-17.64%	-15.77%	-15.77%
TOTAL ASSETS
Total Short-Term Assets	$22.35M	$22.03M	$22.03M
Total Long-Term Assets	$5.893M	$6.222M	$6.222M
Total Assets	$28.24M	$28.25M	$28.25M
YoY Change	-13.8%	-12.7%	-12.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.167M	$3.262M	$3.262M
YoY Change	-5.34%	-7.02%	-7.02%
Accrued Expenses	$2.241M	$2.384M	$3.072M
YoY Change	-9.6%	1.74%	2.93%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$9.386M	$7.686M	$7.686M
YoY Change	1.19%	-12.47%	-12.47%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$496.5K	$623.5K	$1.579M
YoY Change	-56.75%	-52.6%	-35.64%
Total Long-Term Liabilities	$496.5K	$623.5K	$1.579M
YoY Change	-56.75%	-52.6%	-35.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.386M	$7.686M	$7.686M
Total Long-Term Liabilities	$496.5K	$623.5K	$1.579M
Total Liabilities	$10.65M	$9.265M	$9.159M
YoY Change	-7.03%	-17.53%	-17.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.77M	-$38.28M
YoY Change	11.27%	6.83%
Common Stock	$24.85K	$24.85K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.68M	$19.09M	$19.09M
YoY Change
Total Liabilities & Shareholders Equity	$28.24M	$28.25M	$28.25M
YoY Change	-13.8%	-12.7%	-12.7%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.490M	-$1.424M	-$2.448M
YoY Change	-1766.53%	-2362.05%	-166.23%
Depreciation, Depletion And Amortization	$105.9K	$103.4K	$428.3K
YoY Change	-1.07%	-7.87%	-8.83%
Cash From Operating Activities	-$284.9K	-$918.1K	-$1.352M
YoY Change	-115.04%	-413.32%	-390.72%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$28.05K	$314.9K
YoY Change	-100.0%	-299.79%	244.31%
Acquisitions			$0.00
YoY Change
Other Investing Activities	$0.00	-$20.01K	-$4.180K
YoY Change	-100.0%	26.89%	-93.09%
Cash From Investing Activities	$0.00	-$48.08K	-$348.6K
YoY Change	-100.0%	61.29%	62.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	0.000	$0.00
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-$284.9K	-918.1K	-$1.352M
Cash From Investing Activities	$0.00	-48.08K	-$348.6K
Cash From Financing Activities	$0.00	0.000	$0.00
Net Change In Cash	-$284.9K	-966.2K	-$1.700M
YoY Change	-115.43%	-467.07%	-180.05%
FREE CASH FLOW
Cash From Operating Activities	-$284.9K	-$918.1K	-$1.352M
Capital Expenditures	$0.00	$28.05K	$314.9K
Free Cash Flow	-$284.9K	-$946.2K	-$1.667M
YoY Change	-115.71%	-408.13%	-546.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001537435
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2021-01-31#UnrealizedGainLossOnInvestments
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	17403980	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24850261	shares
CY2022	dei	Auditor Name AuditorName	WOLF & COMPANY, P.C.
CY2022	dei	Auditor Firm AuditorFirmId	392
CY2022	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1913969	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3614463	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6714122	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8482286	usd
CY2022Q4	tgen	Employee Retention Credit Current EmployeeRetentionCreditCurrent	713269	usd
CY2021Q4	tgen	Employee Retention Credit Current EmployeeRetentionCreditCurrent	1276021	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1805330	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	3258189	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	10482729	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	7764989	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	401189	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	578801	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	22030608	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	24974749	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1407720	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1782944	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1245549	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1869210	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	997594	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1181023	usd
CY2022Q4	us-gaap	Goodwill Goodwill	2406156	usd
CY2021Q4	us-gaap	Goodwill Goodwill	2406156	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	165230	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	148140	usd
CY2022Q4	us-gaap	Assets Assets	28252857	usd
CY2021Q4	us-gaap	Assets Assets	32362222	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3261952	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3508354	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2384447	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2343728	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1115627	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1957752	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	687589	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	641002	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24850261	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24850261	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24850261	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24850261	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	24850	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	24850	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	57351008	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	57016859	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38281548	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35833621	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	19094310	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	21208088	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-106560	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	-79939	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18987750	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21128149	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28252857	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32362222	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25002614	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24398073	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13935803	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12810420	usd
CY2022	us-gaap	Gross Profit GrossProfit	11066811	usd
CY2021	us-gaap	Gross Profit GrossProfit	11587653	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10909251	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9795823	usd
CY2022	us-gaap	Selling Expense SellingExpense	1811085	usd
CY2021	us-gaap	Selling Expense SellingExpense	2471929	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	732873	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	542079	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	41931	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	10486	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	4674	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	7400	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	13415952	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2349141	usd
CY2022	tgen	Interest And Other Income Expense InterestAndOtherIncomeExpense	-34713	usd
CY2022	us-gaap	Interest Expense InterestExpense	16255	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3773014	usd
CY2021	tgen	Employee Retention Credit EmployeeRetentionCredit	1276021	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	6046	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16352	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19491	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17267334	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	82633	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	202431	usd
CY2021	us-gaap	Profit Loss ProfitLoss	3741017	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21128149	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	76836	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	334149	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18987750	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	469854	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	3773014	usd
CY2022	tgen	Employee Retention Credit EmployeeRetentionCredit	0	usd
CY2021	tgen	Employee Retention Credit EmployeeRetentionCredit	1276021	usd
CY2022	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	-4674	usd
CY2021	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	-7400	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	41931	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	10486	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-70987	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	131206	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	6046	usd
CY2022	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	150000	usd
CY2021	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	0	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	107000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	18749	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-37497	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	334149	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	202431	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2401904	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-57618	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2824740	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	596393	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1452860	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1009060	usd
CY2022	tgen	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-177612	usd
CY2021	tgen	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-18343	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-625320	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	231478	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-246401	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-674750	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-109282	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	374802	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-678758	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	756722	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-645236	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	227271	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1351929	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	465033	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	314879	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	91451	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	72655	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	10486	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	29505	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	63097	usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	11637	usd
CY2022	tgen	Payments To Noncontrolling Interests Investing Activities PaymentsToNoncontrollingInterestsInvestingActivities	76836	usd
CY2021	tgen	Payments To Noncontrolling Interests Investing Activities PaymentsToNoncontrollingInterestsInvestingActivities	82633	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-348565	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-215058	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1874269	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1874269	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1700494	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2124244	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3614463	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1490219	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1913969	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3614463	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	14597	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	241	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	16352	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	19491	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	Nature of business and operationsTecogen Inc. (together with its subsidiaries "we", "our", "us" or "Tecogen"), a Delaware Corporation, was incorporated on September 15, 2000, and acquired the assets and liabilities of the Tecogen Products division of Thermo Power Corporation. We produce commercial and industrial, natural-gas-fueled engine-driven, combined heat and power (CHP) products that reduce energy costs, decrease greenhouse gas emissions and alleviate congestion on the national power grid. Our products supply electric power or mechanical power for cooling, while heat from the engine is recovered and purposefully used at a facility. The majority of our customers are located in regions with the highest utility rates, typically California, the Midwest and the Northeast.Our operations are comprised of three business segments. Our Products segment designs, manufactures and sells industrial and commercial cogeneration systems as described above. Our Services segment provides operation and maintenance services to customers for our products. Our Energy Production segment sells energy in the form of electricity, heat, hot water and cooling to our customers under long-term sales agreements.
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022Q4	tgen	Percentage Of Owned Joint Venture PercentageOfOwnedJointVenture	0.510
CY2022Q4	tgen	Percentage Of Owned Joint Venture PercentageOfOwnedJointVenture	0.510
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2022Q4	tgen	Employee Retention Credit Current EmployeeRetentionCreditCurrent	713269	usd
CY2022Q2	tgen	Proceeds From Employee Retention Credit ProceedsFromEmployeeRetentionCredit	564027	usd
CY2022Q2	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	1275	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that expose us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. We maintain our cash balances in bank accounts, which at times may exceed the Federal Deposit Insurance Corporation’s general deposit insurance limits. The amount on deposit at December 31, 2022 and 2021 which exceeded the $250,000 federally insured limit were approximately $1,393,823 and $3,592,111, respectively. We have not experienced any losses in such accounts and thus believe that we are not exposed to any significant credit risk on cash.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was one customer who represented 12% of revenues for the year ended December 31, 2022 and no customer who represented more than 10% of revenues for the year ended December 31, 2021. There was one customer who represented 15% of the accounts receivable balance as of December 31, 2022, and two customers who represented 14% and 12%, respectively, of the accounts receivable balance as of December 31, 2021.</span></div>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1393823	usd
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3592111	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	361197	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	549206	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	4674	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	7400	usd
CY2022	tgen	Impairment Of Long Lived Production Assets Held For Use ImpairmentOfLongLivedProductionAssetsHeldForUse	156655	usd
CY2021	tgen	Impairment Of Long Lived Production Assets Held For Use ImpairmentOfLongLivedProductionAssetsHeldForUse	0	usd
CY2022	tgen	Reversal Of Unfavorable Contract Liability ReversalOfUnfavorableContractLiability	151981	usd
CY2021	tgen	Reversal Of Unfavorable Contract Liability ReversalOfUnfavorableContractLiability	0	usd
CY2022	tgen	Abandonment Of Patent Applications AbandonmentOfPatentApplications	0	usd
CY2021	tgen	Abandonment Of Patent Applications AbandonmentOfPatentApplications	7400	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	4674	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	7400	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25002614	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24398073	usd
CY2022	tgen	Payment Termon Energy Production Contract Invoices PaymentTermonEnergyProductionContractInvoices	P30D
CY2022	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	1475827	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	1669171	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1487450	usd
CY2022Q4	tgen	Performance Obligation Recognizedover Next Two Years Percent PerformanceObligationRecognizedoverNextTwoYearsPercent	0.94
CY2022Q4	tgen	Performance Obligation Recognizedover Next Twelve Months Percent PerformanceObligationRecognizedoverNextTwelveMonthsPercent	0.19
CY2022Q4	tgen	Performance Obligation Recognizedin Year Two Percent PerformanceObligationRecognizedinYearTwoPercent	0.75
CY2022	us-gaap	Advertising Expense AdvertisingExpense	51000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	47000	usd
CY2022	tgen	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	733000	usd
CY2021	tgen	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	542000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2447927	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2447927	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3696000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3696000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24850261	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24850261	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24850261	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25115518	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2017Q2	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	0	usd
CY2021Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	7000000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	9001491	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6691991	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	498139	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	549802	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	983099	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	523196	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	10482729	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	7764989	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2581672	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1584078	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	997594	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2552168	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1371145	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1181023	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	201043	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	197788	usd
CY2022	tgen	Amortizationof Contract Related Intangible Assetsand Liabilities Net AmortizationofContractRelatedIntangibleAssetsandLiabilitiesNet	274112	usd
CY2021	tgen	Amortizationof Contract Related Intangible Assetsand Liabilities Net AmortizationofContractRelatedIntangibleAssetsandLiabilitiesNet	319084	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	7400	usd
CY2020Q3	tgen	Change In Control Severance Benefit Plan Period In Force Extension ChangeInControlSeveranceBenefitPlanPeriodInForceExtension	P1Y
CY2020Q3	tgen	Change In Control Severance Benefit Plan Notice Period For Cancellation ChangeInControlSeveranceBenefitPlanNoticePeriodForCancellation	P6M
CY2020Q3	tgen	Change In Control Severance Benefit Plan Threshold Period For Termination Prior To Change In Control ChangeInControlSeveranceBenefitPlanThresholdPeriodForTerminationPriorToChangeInControl	P3M
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5290778	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5872993	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3883058	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4090049	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1407720	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1782944	usd
CY2022	tgen	Depreciation Depletionand Amortization Property Plantand Equipment DepreciationDepletionandAmortizationPropertyPlantandEquipment	501418	usd
CY2021	tgen	Depreciation Depletionand Amortization Property Plantand Equipment DepreciationDepletionandAmortizationPropertyPlantandEquipment	591047	usd
CY2022	tgen	Noncash Asset Impairment NoncashAssetImpairment	156655	usd
CY2020Q4	us-gaap	Goodwill Goodwill	2406156	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021Q4	us-gaap	Goodwill Goodwill	2406156	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	2406156	usd
CY2020Q3	tgen	Period Of Severance Benefits For Key Management Employees Under The Plan PeriodOfSeveranceBenefitsForKeyManagementEmployeesUnderThePlan	P12M
CY2020Q3	tgen	Change In Control Severance Benefit Plan Period In Force ChangeInControlSeveranceBenefitPlanPeriodInForce	P3Y
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1311041	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1956277	usd
CY2020Q3	tgen	Change In Control Severance Benefit Plan Threshold Period For Termination After To Change In Control ChangeInControlSeveranceBenefitPlanThresholdPeriodForTerminationAfterToChangeInControl	P18M
CY2022	tgen	Product Warranty Period ProductWarrantyPeriod	P1Y
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	164800	usd
CY2021	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	119752	usd
CY2021	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	119752	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	164800	usd
CY2022	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	208730	usd
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	235730	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	137800	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	733284	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	715639	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	825848	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1245549	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1869210	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	687589	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	641002	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	623452	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1315275	usd
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	84000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	742158	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	249681	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	123908	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	111260	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	52765	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	171086	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1450858	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	139817	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1311041	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24850261	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24850261	shares
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.71
CY2021	tgen	Share Based Compensation Shares Authorized Under Stock Option Plans Granted Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGrantedExercisePriceRangeUpperRangeLimit	10.33
CY2022	tgen	Share Based Compensation Shares Authorized Under Stock Option Plans Granted Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGrantedExercisePriceRangeLowerRangeLimit	1.00
CY2022	tgen	Share Based Compensation Shares Authorized Under Stock Option Plans Granted Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGrantedExercisePriceRangeUpperRangeLimit	1.41
CY2022	tgen	Share Based Compensation Shares Authorized Under Stock Option Plans Cancelled And Forfeited Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansCancelledAndForfeitedExercisePriceRangeLowerRangeLimit	1.00
CY2022	tgen	Share Based Compensation Shares Authorized Under Stock Option Plans Cancelled And Forfeited Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansCancelledAndForfeitedExercisePriceRangeUpperRangeLimit	6.74
CY2022	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.71
CY2022	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	10.33
CY2022	tgen	Share Based Compensation Arrangementby Share Based Payment Award Historical Forfeiture Rate ShareBasedCompensationArrangementbyShareBasedPaymentAwardHistoricalForfeitureRate	0.15
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	5592	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-37497	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	18749	usd
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.045
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	39664	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	37560	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25002614	usd
CY2022	us-gaap	Gross Profit GrossProfit	11066811	usd
CY2022Q4	us-gaap	Assets Assets	28252857	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24398073	usd
CY2021	us-gaap	Gross Profit GrossProfit	11587653	usd
CY2021Q4	us-gaap	Assets Assets	32362222	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9812000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9293000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	310000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	303000	usd
CY2022Q4	tgen	Deferred Tax Asset Tax Deferred Expense Reserves And Accruals Accrued Liabilities And Other DeferredTaxAssetTaxDeferredExpenseReservesAndAccrualsAccruedLiabilitiesAndOther	317000	usd
CY2021Q4	tgen	Deferred Tax Asset Tax Deferred Expense Reserves And Accruals Accrued Liabilities And Other DeferredTaxAssetTaxDeferredExpenseReservesAndAccrualsAccruedLiabilitiesAndOther	338000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	342000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	176000	usd
CY2022Q4	tgen	Deferred Tax Asset Leases DeferredTaxAssetLeases	17000	usd
CY2021Q4	tgen	Deferred Tax Asset Leases DeferredTaxAssetLeases	22000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	96000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	141000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	386000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	288000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	366000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	265000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	705000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	754000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	342000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	270000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12693000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11850000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12693000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11850000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	27366000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	11955000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	843000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001537435-23-000021-index-headers.html	Edgar Link	pending
0001537435-23-000021-index.html	Edgar Link	pending
0001537435-23-000021.txt	Edgar Link	pending
0001537435-23-000021-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tgen-20221231.htm	Edgar Link	pending
tgen-20221231.xsd	Edgar Link	pending
tgen-20221231_g1.jpg	Edgar Link	pending
tgen-20221231_lab.xml	Edgar Link	unprocessable
tgen-20221231_htm.xml	Edgar Link	completed
tgn-20221231xex231.htm	Edgar Link	pending
tgn-20221231xex311.htm	Edgar Link	pending
tgn-20221231xex321.htm	Edgar Link	pending
tgen-20221231_def.xml	Edgar Link	unprocessable
tgen-20221231_cal.xml	Edgar Link	unprocessable
tgen-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TGEN
TECOGEN INC. Stock $tgen

2023 Q1 Form 10-K Financial Statement

#000153743523000021 Filed on March 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TGEN TECOGEN INC. Stock $tgen

2023 Q1 Form 10-K Financial Statement

#000153743523000021 Filed on March 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TGEN
TECOGEN INC. Stock $tgen